| |
| |
|
| Insider
Information: |
Kania Edwin M Jr |
| Relationship: |
10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
19 |
|
| Direct
Shares |
11,446,567 |
|
|
Indirect Shares
|
62,961,806 |
|
|
| Direct
Value |
$115,878,231 |
|
|
|
Indirect Value
|
$160,655,241 |
|
|
| Total
Shares |
74,408,373 |
|
|
| Total
Value |
$276,533,472 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 115.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exact Sciences Corp |
EXAS |
Director |
2009-07-20 |
172,503 |
2009-07-20 |
1,202,787 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
10% Owner |
2013-03-25 |
1,165,786 |
2013-03-25 |
0 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2014-12-23 |
28,734 |
2014-12-23 |
544,055 |
Premium* |
|
|
DNIB Upwind Inc |
BIND |
10% Owner |
2013-09-25 |
0 |
2013-09-25 |
1,562,616 |
Premium* |
|
|
Carisma Therapeutics Inc |
CARM |
10% Owner |
2016-09-23 |
1,940,589 |
|
0 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
2014-02-19 |
656,490 |
|
0 |
Premium* |
|
|
T2 Biosystems, Inc. |
TTOO |
10% Owner |
2014-08-12 |
0 |
2014-08-12 |
2,374,571 |
Premium* |
|
|
Bg Medicine, Inc. |
BGMD |
10% Owner |
2014-12-04 |
0 |
2014-12-11 |
4,915,402 |
Premium* |
|
|
Seres Therapeutics, Inc. |
MCRB |
10% Owner |
|
0 |
2016-05-25 |
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
Director |
2017-05-16 |
26,528 |
2017-05-16 |
560,067 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
10% Owner |
2017-08-17 |
2,378,663 |
2017-08-17 |
262,386 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
10% Owner |
2016-08-11 |
2,764,256 |
2016-08-11 |
45,422 |
Premium* |
|
|
Quanterix Corp |
QTRX |
10% Owner |
2017-12-11 |
2,030,495 |
2017-12-11 |
0 |
Premium* |
|
|
Evelo Biosciences Inc |
EVLO |
10% Owner |
2018-05-11 |
0 |
2018-05-11 |
18,233,403 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
10% Owner |
2018-07-20 |
0 |
2018-07-20 |
7,563,703 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
10% Owner |
2020-01-14 |
23,847 |
2019-12-11 |
20,253,972 |
Premium* |
|
|
Kaleido Biosciences, Inc. |
KLDO |
10% Owner |
|
0 |
2019-03-04 |
2,682,840 |
Premium* |
|
|
Transmedics Group, Inc. |
TMDX |
|
2024-05-23 |
258,676 |
2024-05-23 |
46,142 |
Premium* |
|
|
Axcella Health Inc. |
AXLA |
10% Owner |
|
0 |
2019-05-08 |
2,714,440 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRNA |
Moderna, Inc. |
10% Owner |
– – • |
2019-12-10 |
4 |
S |
$18.96 |
$481,871 |
I/I |
(25,417) |
8,229,132 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
10% Owner |
– – • |
2019-12-11 |
4 |
S |
$18.65 |
$4,445,457 |
I/I |
(238,301) |
8,190,766 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
10% Owner |
– – • |
2020-01-10 |
4 |
S |
$20.34 |
$7,269,972 |
D/D |
(357,375) |
141,472 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
10% Owner |
– – • |
2020-01-14 |
4 |
S |
$20.01 |
$2,353,841 |
D/D |
(117,625) |
23,847 |
0 |
- |
|
79 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
